Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Alnylam Pharmaceuticals (ALNY.MX) Q1 2025 Earnings
ALNY.MX
13
Feb
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-20.18
-14.27
-8.36
-2.46
Details
Expected EPS
-12.083199119999998
Actual EPS
-13.264875
Surprise EPS
-1.18
Surprise Percent
+9.78%
Description
Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -13.264875 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login